|
WO2016071477A1
|
|
Methods for assessing the treatment response of cancer patients and for treating cancer patients by analysing cpg methylation
|
|
WO2015162251A1
|
|
Tumor necrosis factor alpha antagonists for treating viral infections
|
|
WO2015124138A1
|
|
Tumour-associated antigens and gene products in diagnosis and treatment
|
|
EP3015554A1
|
|
Gene expression analysis
|
|
WO2015022211A1
|
|
Method of diagnosing cancer based on med15 and/or med12
|
|
DE102014011258A1
|
|
Tumor associated antigens for diagnosis and therapy
|
|
EP2980218A1
|
|
Aptamer thrombin complex for use as an antidote to direct acting thrombin inhibitors
|
|
EP2977458A1
|
|
Improved strains of Agrobacterium tumefaciens for transferring DNA into plants
|
|
US2015099643A1
|
|
Blood-based gene expression signatures in lung cancer
|
|
DE102014002256A1
|
|
Gene products for diagnosis and therapy
|
|
DE102014101838A1
|
|
Process for the production of biogas from biomass
|
|
EP2839831A1
|
|
Modulators of the unconventional secretory pathway for use in the treatment of Alexander disease
|
|
EP2837694A1
|
|
Method of diagnosing cancer based on MED15 and/or MED12
|
|
DE102013106983A1
|
|
Synthesis of aminated aromatic imide compounds
|
|
EP2821491A1
|
|
Method for producing a drought and salt tolerant plant
|
|
EP2808392A1
|
|
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
DE102013209968A1
|
|
Replication method for surface structures
|
|
EP2796558A1
|
|
Improved gene targeting and nucleic acid carrier molecule, in particular for use in plants
|
|
EP2783691A1
|
|
Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases
|
|
EP2828381A1
|
|
Induced neural stem cells
|
